Invention Grant
- Patent Title: Targeting immunotherapy for amyloidosis
-
Application No.: US16036900Application Date: 2018-07-16
-
Publication No.: US10646568B2Publication Date: 2020-05-12
- Inventor: Jonathan S Wall , Stephen J Kennel , James S Foster
- Applicant: UNIVERSITY OF TENESSEE RESEARCH FOUNDATION
- Applicant Address: US TN Knoxville
- Assignee: UNIVERSITY OF TENESSEE RESEARCH FOUNDATION
- Current Assignee: UNIVERSITY OF TENESSEE RESEARCH FOUNDATION
- Current Assignee Address: US TN Knoxville
- Agency: FisherBroyles, LLP
- Agent Jason M. Pass
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P27/02 ; A61K39/395 ; C07K16/18 ; C07K14/47 ; A61K47/66 ; A61K47/68 ; A61K51/10 ; G01N33/53 ; G01N33/68 ; A61K39/00

Abstract:
Disclosed are methods and compositions for targeting antibodies to amyloid deposits. For example, amyloid-reactive peptides that bind amyloid deposits are administered to a subject. Antibodies to the amyloid-reactive peptides are then administered to the subject. Upon administration of the antibodies, the amyloid-reactive peptides bind the antibodies and thus pre-target the antibodies to the amyloid deposits. In other examples, an amyloid-reactive fusion peptide contains an epitope of a known antibody. When the fusion peptide is administered to a subject, the fusion peptide binds amyloids in the subject. Administration to the subject of the known antibody that binds the epitope of the fusion peptide then targets the antibody to the amyloid deposit to which the fusion peptide is bound.
Public/Granted literature
- US20190083616A1 TARGETING IMMUNOTHERAPY FOR AMYLOIDOSIS Public/Granted day:2019-03-21
Information query
IPC分类: